1-2 of 2
Donald E Tsai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Follicular Lymphoma: Phase 1/2 BRUIN Study

Open Access
Clinical Trials & Observations
Nirav N Shah, Pier Luigi Zinzani, Michael L Wang, Sunita D. Nasta, Ewa Lech-Maranda, Yoshiaki Ogawa, Bita Fakhri, Bryone Jean Kuss, Kaname Miyashita, Krish Patel, Catherine C. Coombs, Shuo Ma, Manish R. Patel, Minal Barve, Benoit Tessoulin, Anastasios Stathis, Daisuke Ennishi, Daigo Hashimoto, Kensuke Kojima, Andrew D. Zelenetz, Jonathon B Cohen, Julie M Vose, Kami J Maddocks, Talha Munir, Fangfang Sun, Yuanyuan Bian, Minna Balbas, Donald E Tsai, Paolo B. Abada, Chan Y Cheah
Journal: Blood Advances
Blood Adv bloodadvances.2024014975.
https://doi.org/10.1182/bloodadvances.2024014975
Published: 2025
Includes: Supplemental data
Journal Articles

Tabelecleucel for EBV + PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol

Free
Clinical Trials & Observations
Sarah Nikiforow, Jennifer S. Whangbo, Ran Reshef, Donald E. Tsai, Nancy Bunin, Rolla Abu-Arja, Kris Michael Mahadeo, Wen-Kai Weng, Koen Van Besien, David Loeb, Sunita Dwivedy Nasta, Eneida R. Nemecek, Weizhi Zhao, Yan Sun, Faith Galderisi, Justin Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan Prockop
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3001–3012.
https://doi.org/10.1182/bloodadvances.2023011626
Published: 2024
Includes: Supplemental data